For a special limited time:

         Save 30%!

 Get all 3:

           currinBiotech.com
 
            currinTechnology
  
                       and
  
              rick'sResearch

       
  
  for one low price.

                Learn more

You are here: Home » Premium Membership.

Premium Membership.

Print

Thank you for your interest in CurrinBiotech.com.

The CurrinBiotech newsletter is a monthly e-newsletter service complete with portfolio selections, special updates and features, and transaction alerts. For more information feel free to call us Toll Free at

(877) 654 - CBIO


The membership is $350 and is renewable after 12 months.

Purchase with or without a Pay Pal account.




Secure card processing




To get a free report and sample newsletter just provide your email address.  You risk nothing. 

 

What You Get

Each month we cover the investments selected for developments important to your investment
decisions.  This includes looking at parallel development and pipeline activity and the business
model as applied to your investment.   

Breaking Science


Each month we take a look at the science of the biotech area.  While biotech companies will
often deliver press releases on the positive developments in an animal or clinical study,
scientific research can often define the true under the radar direction of drug candidates. 

We look at breaking science for what it gives us as confirmation or perhaps even contradiction
of investments.  By using this approach you stay invested in the most promising science and
avoid the disasters of late stage disappointments.

Gems on the Forefront


We deliver the gems on the forefront each month.  No biotech investment portfolio is complete
without some exposure to mid stage developments. 

While a mix of mid stage and later stage pipelines is important generally, it is the early to mid
stage areas that provide the 10 to 20 baggers as well as the huge upside potential of partnerships
and acquisitions by big pharma in the long term.  

Also looking at mid stage developments (and sometimes even early developments and
non-publicly traded activity) gives you early signals on what late stage drugs are facing in terms
of promise and pitfalls. 

By taking a look at gems on the forefront in every issue we arm you with the knowledge to
navigate biotech for the largest profits.  We will show you in every issue that hidden gems are
not so hidden after all.


Stock Selection and Portfolios


We feature model portfolios for our selections.  You have access to all the portfolio information
and recommendations in the member area as well as access to archived content and alerts.


Unlimited Online Access, Alerts and Special Features


In addition to the monthly service for tracking your investment decisions, you will also receive
email alerts for transactions and special feature reports as supplemental reports.  All of the
information in the monthly service is available online with unlimited access.


A Simple Effective Approach


The CurrinBiotech newsletter is easy to use and understand.  Buy the longer term portfolio stocks
we feature in our portfolio section and monitor the investments as well as market developments
with our newsletter and transaction alerts. 

While the system is simplicity in action, it is knowing which stocks to select based on knowledge
of the science and innovation and market potential that is key to its success.  That's where the
research of the CurrinBiotech and our collaboration team comes in to bring you clear, confident,
money-making picks.